Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

MIRAMIRA
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in MIRA PHARMACEUTICALS INC

Yes. Citadel Advisors holds 18,661 shares of MIRA (Mira Pharmaceuticals), worth $17,663, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$17,663

Current Shares

18,661

Total Value Change

+$1,610

Total Shares Change

-5,735

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
18,661
-
$17,6630.0%$0.95
28
2025-Q1
Exited
0
-100.0%
$00.0%$0.98
0
2024-Q4
New
97,976
-
$111,6930.0%$1.14
34
2024-Q3
Exited
0
-100.0%
$00.0%$1.30
0
2024-Q2
New
24,396
-
$16,0530.0%$0.64
28

Other major holders of MIRA: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used